Recent advances in antibiotics.
D000583:Amikacin / Q000494:pharmacology; D000617:Aminoglycosides / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy; D002511:Cephalosporins / Q000494:pharmacology; D002513:Cephamycins / Q000494:pharmacology; D005437:Flucytosine / Q000494:pharmacology; D005839:Gentamicins / Q000494:pharmacology; D008795:Metronidazole / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology; D010957:Plasmids / Q000187:drug effects; D012853:Sisomicin / Q000494:pharmacology; D014031:Tobramycin / Q000494:pharmacology
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D002511:Cephalosporins; D002513:Cephamycins; D005839:Gentamicins; D010406:Penicillins; D008795:Metronidazole; D000583:Amikacin; D005437:Flucytosine; D014031:Tobramycin; D012853:Sisomicin